Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32417996
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 World+J+Urol
2021 ; 39
(3
): 823-827
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
BCG versus COVID-19: impact on urology
#MMPMID32417996
Desouky E
World J Urol
2021[Mar]; 39
(3
): 823-827
PMID32417996
show ga
PURPOSE: To search for evidence base for using BCG in the fight against COVID-19
and the possible impact of these clinical trials on urology practice. METHODS: A
literature review about the basis of the ongoing clinical trials using BCG
against COVID-19, as well as the use of BCG in urology and if there are any
implications of these trials on our practice. RESULTS: Based on data from some
epidemiological studies, there are some current clinical trials on the use BCG as
a possible prophylactic vaccine against SARS CoV-2 which can affect urology
practice. Urologists are already struggling with the global shortage of BCG which
can be even more aggravated by such trials. In addition, if the ongoing trials
proved the efficacy of BCG as a prophylaxis against COVID-19, this may open the
door to more urological research opportunities to question the possibility that
intra-vesical BCG, given its systemic immunologic effect, may have been
protective to this subgroup of urological patients. CONCLUSION: The ongoing
clinical trials using BCG against COVID-19 can affect our urology practice. We
need to stay vigilant to such impacts: BCG shortage and possible new chances for
urology research work.
|Adjuvants, Immunologic/supply & distribution/*therapeutic use
[MESH]
|Administration, Intravesical
[MESH]
|BCG Vaccine/supply & distribution/*therapeutic use
[MESH]
free
free
free
